91Ó°ÊÓ

Asthma and COPD are both respiratory disorders, but they have different causes. Asthma is primarily caused by genetic and environmental factors, such as a family history of asthma, allergies, or exposure to allergens like pollen, pet dander, and dust mites. Other triggers include: respiratory infections, exercise, cold air, and certain medications. COPD, on the other hand, is primarily caused by long-term exposure to harmful substances like tobacco smoke, air pollution, and occupational dust and chemicals. Other risk factors include a genetic predisposition (alpha-1 antitrypsin deficiency) and aging.

Asthma and COPD both involve inflammation and narrowing of the airways, but the specific mechanisms differ between the two conditions. In asthma, the airways become inflamed and swollen, leading to bronchoconstriction (narrowing of the airways), increased mucus production, and airway hyperresponsiveness (an exaggerated response to triggers). These changes make it difficult for air to flow in and out of the lungs, causing the characteristic wheezing, chest tightness, and shortness of breath. COPD includes two main conditions: chronic bronchitis and emphysema. Chronic bronchitis involves inflammation and thickening of the bronchial tubes, along with increased mucus production. Emphysema is characterized by damage to the alveoli (tiny air sacs in the lungs) and loss of lung elasticity, leading to shortness of breath and reduced ability to exhale fully. Both conditions cause airflow obstruction and impaired gas exchange, leading to hypoxemia (low levels of oxygen in the blood) and hypercapnia (elevated levels of carbon dioxide in the blood).

Although asthma and COPD are both chronic conditions, the treatment strategies differ significantly. The main goal of asthma treatment is to control symptoms and prevent acute exacerbations (asthma attacks) by using medications like short-acting and long-acting bronchodilators (to relax the muscles around the airways) and inhaled corticosteroids (to reduce inflammation). Asthma patients also benefit from avoiding triggers and having an action plan in place to manage acute symptoms. COPD treatment, on the other hand, focuses on managing symptoms, slowing the progression of the disease, and preventing acute exacerbations. Key components of COPD treatment include: quitting smoking, using bronchodilators (to widen the airways), inhaled corticosteroids (to reduce inflammation), supplemental oxygen therapy (for severe cases with low blood oxygen levels), pulmonary rehabilitation (to improve exercise capacity and self-management skills), and vaccinations (to prevent respiratory infections). In severe cases, surgical treatments like lung volume reduction surgery or lung transplantation may be considered.